Artificial intelligence and machine learning companies develop software, algorithms and computational platforms that analyse biological data, automate workflows and accelerate scientific discovery. These technologies are increasingly used across drug discovery, diagnostics, genomics and healthcare research.
This category includes companies working on:
Browse 243 UK AI and machine learning companies below.
AI-powered gut microbiome analysis for personalised clinical nutrition
Enbiosis is a biotechnology company combining whole-genome gut microbiome sequencing with artificial intelligence to generate personalised nutrition, dietary, and supplement recommendations for patients with gastrointestinal disorders. Its B2B platform is used by healthcare professionals including gastroenterologists…
AI-designed aptamer therapeutics for undruggable targets
PentaBind is a TechBio company using generative AI to design aptamers with drug-like properties for targets that are inaccessible to conventional modalities. Its platform combines proprietary datasets with wet-laboratory validation to deliver multi-attribute aptamer candidates in a fraction of the time and cost of…
AI clinical decision support for macular and retinal disease
Macusoft is a London-based health technology company developing AI-powered software to support clinical decision-making in ophthalmology. Its platform assists with diagnosis, triage, and treatment recommendations for macular diseases, diabetic retinopathy, and related retinal conditions, drawing on imaging data and…
AI-powered EEG platform for CNS clinical trials
Cumulus Neuroscience is a digital health software company providing an integrated brain monitoring and analytics platform for neuroscience clinical trials. Its platform combines a medical-grade EEG headset with machine learning analytics to generate objective, at-home physiological and cognitive biomarker data.…
AI-powered software for large-scale microscopy and scientific data
Dataflight Solutions is a scientific software company developing infrastructure for processing, visualising and analysing large biological datasets. Its technology focuses on high-volume three-dimensional fluorescence microscopy, using adaptive data representations to reduce storage and computation requirements. The…
AI epigenomics platform for neurodegenerative disease detection
Prima Mente is a biotechnology company developing large-scale biological foundation models to understand and detect neurodegenerative disease. The company generates proprietary multi-omic data including whole-epigenome sequencing, and trains transformer-based models on DNA methylation patterns in cell-free DNA to…
AI-native platform for cell culture process design and optimisation
Tolemy Bio Ltd is a company developing an AI-native platform for cell therapy process development and manufacturing optimisation. The platform ingests experimental and bioreactor data including cell growth, phenotype, potency, and metabolite profiles, then applies causal AI models to identify the biological drivers of…
Multimodal engineered T-cell therapies for treatment-refractory solid cancers
Alceus Bio is a biotechnology company developing next-generation engineered T-cell therapies for solid tumours. Its platform uses generative AI and synthetic biology to design therapeutic proteins that patient-derived immune cells are programmed to express and deliver in situ, targeting intracellular disease drivers…
AI-ready toxicity datasets for preclinical drug discovery
Biolligence is a biotechnology company developing AI-ready toxicity datasets and predictive tools for the drug discovery industry. The company combines deep learning algorithms with stem cell-derived in vitro models and clinical data to generate mechanistic toxicity information aimed at reducing dependence on animal…
AI platform designing vaccines against current and future pathogens
Baseimmune is a biotechnology company developing a deep learning platform for computational vaccine antigen design. The platform integrates genomic, epidemiological, immunological, and evolutionary data to generate novel synthetic antigens drawn from across an entire pathogen genome, enabling the design of vaccines…
Precision medicine platform matching cancer patients to optimal therapies
Pathway Bio is a precision oncology company developing a functional platform to predict treatment response in individual cancer patients. The platform combines multiomic tumour profiling, AI-driven modelling, and ex vivo microcancer technology to screen therapies against a biological avatar of the patient's own tumour…
Genomic risk prediction platform for preventive healthcare and drug discovery
Genomics is a data science company that uses large-scale human genetic data to power precision healthcare and drug discovery. Its proprietary platform links millions of genetic variants to thousands of biological measurements and disease outcomes, generating polygenic risk scores that enable earlier identification of…
Modular microfluidic and automation systems for autonomous biology labs
Engivent develops modular microfluidic hardware and automation software for biological laboratories. Its platform combines microfluidic chips, laboratory robotics, sensing and structured data capture into programmable experimental workflows. The company is building towards closed-loop systems in which results inform…
AI echocardiography platform for heart failure detection
Ultromics is an Oxford University spin-out developing AI-powered software that analyses routine echocardiogram images to detect complex cardiac conditions. Its cloud-based platform holds multiple FDA clearances and CE marks for heart failure with preserved ejection fraction and cardiac amyloidosis screening. The…
Novel mode-of-action herbicide discovery platform
Moa Technology discovers synthetic and biological herbicides with novel modes of action to address herbicide resistance. Its high-throughput platform uses miniaturised living plants, high-content microscopy and AI to identify new compounds. The company has screened more than 900,000 compounds and identified over 80…
No-code digital experiment platform for life science R&D
Synthace provides cloud-based software that enables life science researchers to design, automate and analyse experiments without writing code. Its platform integrates with laboratory automation hardware, structures experimental data and applies design of experiments methodologies, with a primary focus on assay…
Biostatistics, clinical trial simulation and data science services
Exploristics is a Belfast-based provider of biostatistics, data science, and clinical trial simulation software and services to the pharmaceutical, biotechnology, medical diagnostics, and device sectors. The company supports clinical development programmes from early-phase design through to regulatory submission,…
AI-driven delivery platform for siRNA therapies beyond the liver
Undecimal Bio is a biotechnology company developing targeted delivery technologies for small interfering RNA (siRNA) therapeutics beyond the liver. Its DELiveri platform combines large-scale combinatorial chemistry, functional cell-based screening and AI to identify synthetic conjugates that transport siRNA into…
AI-driven drug discovery targeting intrinsically disordered proteins
Peptone is a translational biophysics company developing novel therapeutics against intrinsically disordered proteins (IDPs), a class of structurally dynamic proteins implicated in cancer, inflammation and metabolic disease. The company combines hydrogen-deuterium exchange mass spectrometry, high-performance…
AI-powered stain-free digital pathology for liver fibrosis quantification
HistoIndex is a contract digital pathology organisation providing quantitative histology services for clinical trials and diagnostics, with a primary focus on liver fibrosis in metabolic liver disease. Its platform combines stain-free microscopy with artificial intelligence to generate objective, reproducible fibrosis…